ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$2.39 USD
+0.06 (2.58%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.39 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.78 | 0.00% |
Earnings Summary
For their last quarter, ALX Oncology Holdings (ALXO) reported earnings of -$0.76 per share, beating the Zacks Consensus Estimate of $-0.77 per share. This reflects a positive earnings surprise of 1.30%. Look out for ALXO's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.78 per share, reflecting a year-over-year increase of 37.1%.
Earnings History
Price & Consensus
Zacks News for ALXO
IDEAYA (IDYA) Up on Upbeat Phase II Bladder & Lung Cancer Data
ALXO: What are Zacks experts saying now?
Zacks Private Portfolio Services